In the months following Elon Musk’s $44 billion acquisition of Twitter in 2022, my experience with the platform (and perhaps yours too) got quickly, dramatically worse. My algorithmic timeline, better ...
Most of you used a navigation app like Google Maps for your travels at some point. These apps rely on algorithms that compute shortest paths through vast networks. Now imagine scaling that task to ...
Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...
In case you had any doubt, Elon Musk’s X has an algorithm that favors conservative content posted by political activists over liberal content or posts by traditional news media accounts, according to ...
Posts from this topic will be added to your daily email digest and your homepage feed. If you want to tweak what’s on your feed, you can make a post and ask. If you want to tweak what’s on your feed, ...
The EU is threatening to take action against the social media company. It could be the start of a global reckoning. Katie is a UK-based news reporter and features writer. Officially, she is CNET's ...
The X logo appears on a smartphone screen. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images) (NurPhoto via Getty Images) When X's engineering team published the code that powers the platform's ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. TikTok has reached a deal that will allow it to keep operating in the United States, with a majority American-owned joint ...
In 2023, the website then known as Twitter partially open sourced its algorithm for the first time. In those days, Tesla billionaire Elon Musk had only recently acquired the platform, and he claimed ...
Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results